Pharmexcil appoints Ravi Uday Bhaskar as DG

By Sanjiv Das on January 12, 2017

Ravi Uday Bhaskar, present Addl. Executive Director, Pharmexcil has been appointed as the Director General of the Council with effect from 30.12.2016.

Related Posts

Optimising cloud provisioning for pharmaceutical compliance and operational excellence

Accelerating pharma’s sustainability efforts

Granules India presented with the Golden Peacock Award for sustainability

Paratek Phase IIb data shows omadacycline’s potential to address unmet needs in NTM treatment, says GlobalData

AstraZeneca invests $3.5 bn in R&D and manufacturing in the US

Cadila Pharmaceuticals launches iron supplement ‘Militol’

AstraZeneca India, Indian Academy of Paediatrics unite to raise awareness on respiratory syncytial virus in India